Joseph G. Wettstein
Basel, BS 4070, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Behavioral and pharmacological validation of the differential reinforcement of low-rate behavior paradigm in non-human primates.
Journal: Behavioural pharmacology
Published: March 17, 2026
Preface to cognitive enhancement.
Journal: Handbook of experimental pharmacology
Published: August 29, 2015
Closing thoughts for cognitive enhancement.
Journal: Handbook of experimental pharmacology
Published: May 16, 2015
Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: March 06, 2015
Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.
Journal: The Journal of pharmacology and experimental therapeutics
Published: February 11, 2015
Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases.
Journal: Journal of medicinal chemistry
Published: January 08, 2015
Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome.
Journal: Current opinion in pharmacology
Published: October 31, 2014
"Domain gauges": A reference system for multivariate profiling of brain fMRI activation patterns induced by psychoactive drugs in rats.
Journal: NeuroImage
Published: August 20, 2014
Homer1/mGluR5 activity moderates vulnerability to chronic social stress.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: June 04, 2014
Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study.
Journal: JAMA psychiatry
Published: April 04, 2014
Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: March 01, 2013
The CRTC1-SIK1 pathway regulates entrainment of the circadian clock.
Journal: Cell
Published: January 08, 2013
Last Updated: 09/26/2026